Erawat Pharma Limited - Company Profile

It is a healthcare public limited company based in Indore, Madhya Pradesh, India, established in 1993.
1993 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Erawat Pharma Limited

Erawat Pharma Limited, a active public limited company, was established on 01 March 1993 in Indore, Madhya Pradesh, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U02423MP1993PLC007538. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹6.95 Cr and a paid-up capital of ₹6.75 Cr.

Formerly known as Erawat Pharma Private Limited. It upholds a compliant status. Employing 175 professional, Its leadership includes Amit Jain (Whole-Time Director), Vasant Raj Solanki (Director), Devindar Singh Sodhi (Director). Past directors included Vinod Gokulchand Kataria, Raj Kirtani, Amit Jain. It holds ₹50.00 Cr open charges and ₹29.78 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12C, F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U02423MP1993PLC007538

  • Registration Number

    007538

  • Incorporation Date

    01 March 1993

  • Authorized Capital

    ₹6.95 Cr

  • Paid-Up Capital

    ₹6.75 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.95 Cr
  • Paid Up Capital ₹ 6.75 Cr
  • Company Age 33 Year, 5 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 50.00 Cr
  • Satisfied Charges ₹ 29.78 Cr
  • Revenue Growth **** 7.01%
  • Profit Growth **** -13.38%
  • Ebitda **** -3.55%
  • Net Worth 32.24%
  • Total Assets **** 19.05%
Company report

Erawat Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Erawat Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Erawat Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Amit Jain Whole-Time Director 01 Oct 2018 Current
Vasant Raj Solanki Director 16 Aug 1994 Current
Devindar Singh Sodhi Director 30 Apr 1997 Current
Hemchandra Jain Managing Director 01 Mar 1993 Current
Abhijeet Jain Whole-Time Director 01 Oct 2018 Current
Abhishek Jain Whole-Time Director 11 Jul 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Jul 2015 Past
Pramod Abcsdd Director 18 Oct 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary 01 Apr 2020 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Erawat Pharma.

Erawat Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.01% increase. The company also saw a substantial fall in profitability, with a 13.38% decrease in profit. The company's net worth Soared by an impressive increase of 32.24%.

Erawat Pharma revenue growth over time
Erawat Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.01%
*******
*******
*******
*******
Revenue from Operations
*******
 7.12%
*******
*******
*******
*******
Total Assets
*******
 19.05%
*******
*******
*******
*******
Profit or Loss
*******
 -13.38%
*******
*******
*******
*******
Net Worth
*******
 32.24%
*******
*******
*******
*******
EBITDA
*******
 -3.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Erawat Pharma?

In 2023, Erawat Pharma had a promoter holding of 80.70% and a public holding of 19.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹499,951,115.00

Satisfied Charges

₹297,750,000.00

Charges Breakdown by Lending Institutions
  • Others : 47.90 Cr
  • Sidbi : 2.10 Cr
Latest Charge Details
Date Lender Amount Status
20 Nov 2024 Sidbi ₹8.18 M Open
26 Feb 2024 Others ₹8.91 M Open
22 Nov 2023 Sidbi ₹1.28 Cr Open
13 Apr 2023 Others ₹8.24 Cr Open
21 Oct 2022 Others ₹6.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Erawat Pharma?

Erawat Pharma has a workforce of 175 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Erawat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erawat Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Erawat Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Sidbi amounted to Rs. 0.82 Cr with Charge ID 101006106 was registered on 20 Nov 2024. was documented.

  • Annual General Meeting

    Progress on Erawat Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    A charge with Others of Rs. 0.89 Cr registered on 26 Feb 2024 with Charge ID 100886118 was modified on 09 Aug 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Others of Rs. 6.00 Cr registered on 21 Oct 2022 with Charge ID 100628027 was modified on 09 Aug 2024. was completed.

  • Charges

    The activity A charge with Others of Rs. 0.69 Cr registered on 21 Oct 2022 with Charge ID 100627269 was modified on 09 Aug 2024. was completed.

  • Charges

    A charge with Others of Rs. 0.43 Cr registered on 21 Oct 2022 with Charge ID 100627262 was modified on 09 Aug 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Erawat Pharma Limited?

The CIN of Erawat Pharma Limited is U02423MP1993PLC007538.

Where is Erawat Pharma Limited headquartered?

Erawat Pharma Limited is headquartered at 12C, F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, 452010.

When was Erawat Pharma Limited incorporated?

Erawat Pharma Limited was incorporated on 01 March 1993.

Who are the current directors of Erawat Pharma Limited?

The current directors of Erawat Pharma Limited are

What is the primary industry of Erawat Pharma Limited?

The primary industry of Erawat Pharma Limited is Manufacturing.

Is Erawat Pharma Limited a listed company?

Erawat Pharma Limited is unlisted.

What is the capital structure of Erawat Pharma Limited?

The authorized capital of Erawat Pharma Limited is ₹6.95 Cr, and the paid-up capital is ₹6.75 Cr.

What is the compliance status of Erawat Pharma Limited?

The compliance status of Erawat Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available